HHRA Phase 3: Screening-Level Deterministic Risk Calculations, Revised (2000)
Learn whether substances other than lead pose a potential concern in Trail. This phase further evaluates risks associated with arsenic and cadmium, incorporating new data from air and indoor dust monitoring. The potential for adverse health effects from long-term residence in Trail was limited. Continued monitoring of air concentrations for arsenic and cadmium was recommended.
HHRA Phase 3: Screening-Level Deterministic Risk Calculations, Revised (2000) Read More »









